Sequential decision making in merger control

We model merger control procedures as a process of sequential acquisition of information and compare US and EU procedures. In the US, the authorities do not have to justify their decision to require further information (issue a second request),whereas in the EU, the authorities face a different (enforceable) standard of proof in phase I relative to phase II. We found that in the absence of remedies, the US procedure is always superior in terms of expected consumer welfare. When we allow for remedies, we found that, compared to the US, merging parties in the EU have more scope to propose remedies in phase I that will preempt the authorities from uncovering unfavorable information in phase II, and this might reduce expected consumer welfare. However, the higher standard of proof in phase I can also in some circumstances act as a commitment not to accept remedies below some threshold and yield a higher expected consumer welfare in the EU. Our model also shows that for global mergers that have the same effect in the two jurisdictions, a decision to trigger a Phase II in the EU yields the same expected consumer welfare as a clearance in Phase I with remedies in the US. However, the converse is not true.

Institutions

Publication Details

Journal
Graduate Institute Geneva Institutional Repository (Graduate Institute of International and Development Studies)
Published
2025-03-24
DOI
https://doi.org/10.71609/iheid-fj30-hd04
Primary Topic
Fetal and Pediatric Neurological Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Sequential decision making in merger control

Graduate Institute Geneva Institutional Repository (Graduate Institute of International and Development Studies)
Fetal and Pediatric Neurological Disorders
article

Sequential decision making in merger control

article en

Abstract

We model merger control procedures as a process of sequential acquisition of information and compare US and EU procedures. In the US, the authorities do not have to justify their decision to require further information (issue a second request),whereas in the EU, the authorities face a different (enforceable) standard of proof in phase I relative to phase II. We found that in the absence of remedies, the US procedure is always superior in terms of expected consumer welfare. When we allow for remedies, we found that, compared to the US, merging parties in the EU have more scope to propose remedies in phase I that will preempt the authorities from uncovering unfavorable information in phase II, and this might reduce expected consumer welfare. However, the higher standard of proof in phase I can also in some circumstances act as a commitment not to accept remedies below some threshold and yield a higher expected consumer welfare in the EU. Our model also shows that for global mergers that have the same effect in the two jurisdictions, a decision to trigger a Phase II in the EU yields the same expected consumer welfare as a clearance in Phase I with remedies in the US. However, the converse is not true.

Graduate Institute Geneva Institutional Repository (Graduate Institute of International and Development Studies)
Graduate Institute of International and Development Studies (CH)
Peace, Justice and strong institutions
Openalex Percentile: Top 40%
Fetal and Pediatric Neurological Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.